A detailed history of Baldwin Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baldwin Investment Management, LLC holds 11,149 shares of BMY stock, worth $656,341. This represents 0.15% of its overall portfolio holdings.

Number of Shares
11,149
Previous 11,849 5.91%
Holding current value
$656,341
Previous $492,000 17.07%
% of portfolio
0.15%
Previous 0.07%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $27,761 - $36,225
-700 Reduced 5.91%
11,149 $576,000
Q2 2024

Jul 30, 2024

SELL
$40.25 - $52.99 $226,607 - $298,333
-5,630 Reduced 32.21%
11,849 $492,000
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $31,186 - $35,360
-650 Reduced 3.59%
17,479 $947,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $736,168 - $878,452
-15,185 Reduced 45.58%
18,129 $930,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $1.22 Million - $1.36 Million
-21,021 Reduced 38.69%
33,314 $1.93 Million
Q2 2023

Aug 01, 2023

SELL
$63.71 - $70.74 $451,194 - $500,980
-7,082 Reduced 11.53%
54,335 $3.47 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $129,514 - $146,898
-1,971 Reduced 3.11%
61,417 $4.26 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $77,040 - $91,226
-1,125 Reduced 1.74%
63,388 $4.56 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $689 - $407,328
-5,301 Reduced 7.59%
64,513 $4.59 Million
Q2 2022

Aug 02, 2022

SELL
$72.62 - $79.98 $204,933 - $225,703
-2,822 Reduced 3.89%
69,814 $5.38 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $100,827 - $120,900
1,640 Added 2.31%
72,636 $5.31 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $260,963 - $304,222
-4,866 Reduced 6.41%
70,996 $4.43 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $46,803 - $54,824
791 Added 1.05%
75,862 $4.49 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $176,319 - $192,012
2,848 Added 3.94%
75,071 $5.02 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $277,473 - $312,076
4,676 Added 6.92%
72,223 $4.56 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $632,945 - $717,243
10,962 Added 19.37%
67,547 $4.19 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $987,738 - $1.09 Million
17,199 Added 43.67%
56,585 $3.41 Million
Q2 2020

Jul 27, 2020

BUY
$54.82 - $64.09 $41,992 - $49,092
766 Added 1.98%
39,386 $2.32 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $277,240 - $402,894
5,975 Added 18.3%
38,620 $2.15 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $1.07 Million - $1.39 Million
21,720 Added 198.81%
32,645 $2.1 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $29,554 - $35,040
691 Added 6.75%
10,925 $554,000
Q2 2019

Aug 06, 2019

BUY
$44.62 - $49.34 $456,641 - $504,945
10,234 New
10,234 $464,000
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $185,398 - $221,064
-4,109 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $22,076 - $24,900
-400 Reduced 8.87%
4,109 $255,000
Q2 2018

Aug 15, 2018

BUY
$50.53 - $62.98 $227,839 - $283,976
4,509 New
4,509 $250,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Baldwin Investment Management, LLC Portfolio

Follow Baldwin Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.